Therapy Areas: Vaccines
Broadhurst Named to Zoetis Board of Directors
25 July 2022 - - US-based Zoetis Inc. (NYSE: ZTS) has appointed Vanessa Broadhurst, executive vice president, Global Corporate Affairs at Johnson and Johnson (NYSE: JNJ), to its board of directors, the company said.

Broadhurst has experience in consumer insights and direct-to-consumer advertising, and her appointment increases the size of the board from 11 to 12 members.

She will serve on the board's Quality and Innovation Committee.

Broadhurst is a member of Johnson and Johnson's Executive Committee and leads the company's global marketing, communication, design and philanthropy functions, in addition to having oversight of Johnson and Johnson Health and Wellness Solutions.

Prior to her appointment to the Executive Committee in 2022, Broadhurst was company Group chairman, Global Commercial Strategy for Pharmaceuticals.

In that role, she led a team focused on commercialization and launch strategies across the company's broad pipeline of products, spanning six therapeutic areas.

Additionally, she had oversight of global value and access, global commercial data sciences, and global medical affairs across the portfolio of pharmaceutical products.

Broadhurst serves as a member of The Executive Leadership Council (ELC), a preeminent association of Black business leaders, which focuses on board and executive leadership development, philanthropy, skills and talent development.

She is also a Board member of the Ad Council, an American nonprofit organization that produces, distributes, and promotes public service announcements on behalf of various sponsors, including non-profit organizations, non-governmental organizations and agencies of the United States government.

She received a Master of Business Administration from the Ross School of Business at University of Michigan, where she was a Consortium Fellow, and a Bachelor of Arts degree from the University of Colorado, Boulder.

Zoetis has a portfolio and pipeline of medicines, vaccines, diagnostics, and technologies.